Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.

Annals of surgical oncology·2025

Same author

Impact of a 7-Gene Predictive Biosignature on Adjuvant Radiation Therapy Recommendations in Patients Undergoing Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Journal of the American College of Surgeons·2025

Same author

Lymph Node Positivity: Indication for Preoperative MRI?

Annals of surgical oncology·2023

Same author

ASO Author Reflections: Lymph Node Positivity: Indication for Preoperative MRI?

Annals of surgical oncology·2023

Same author

The evaluation of the delayed swollen breast in patients with a history of breast implants.

Frontiers in oncology·2023

Same author

ASO Author Reflection: Outcomes of Abbreviated MRI for Women of Any Breast Cancer Risk and Breast Density.

Annals of surgical oncology·2022

Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026

Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 16, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

Individualizing Breast Cancer Risk Assessment in Clinical Practice.

Amy E Cyr¹, Kaitlyn Kennard²

¹Department of Medicine, Washington University, Box 8056, 660 South Euclid Avenue, Saint Louis, MO 63110, USA.

Surgical Oncology Clinics of North America

|September 15, 2023

Summary

This summary is machine-generated.

Choosing the right breast cancer risk assessment tool is crucial for patient care. Accurate risk calculation guides decisions on supplemental screening, preventive therapies, and lifestyle changes for high-risk individuals.

Keywords:

Breast cancer risk High risk Risk assessment Risk factors Risk models Risk reduction Screening

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Experiment Videos

Last Updated: Jul 16, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Area of Science:

Oncology
Medical Informatics

Background:

Numerous breast cancer risk assessment tools are available.
The selection and application of these tools are critical for clinical decision-making.

Purpose of the Study:

To highlight the importance of selecting appropriate breast cancer risk models.
To explain how different risk thresholds influence patient management strategies.

Main Methods:

Review of current breast cancer risk assessment models and their clinical applications.
Analysis of risk stratification criteria for guiding patient care.

Main Results:

Lifetime risk ≥20% identifies patients eligible for supplemental breast MRI screening.
5-year risk ≥1.66% indicates patients who should be offered endocrine prophylaxis.
High-risk patients benefit from guidance on modifiable lifestyle factors.

Conclusions:

Tailoring risk assessment to individual patient factors ensures optimal care pathways.
Risk stratification is essential for implementing timely and effective breast cancer prevention and screening strategies.